V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220019327 | 220007164 | 1.65 | 99 | Curative (C) | 2016-02-28 | 2016-06-05 | AML18 PILOT TRIAL | N | Y | 220027518 | PILOT TRIAL |
| 220019328 | 220007166 | 1.75 | 103.8 | Curative (C) | 2015-03-03 | 2015-03-17 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | Y | N | 220027534 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019329 | 220013953 | 1.69 | 86.5 | Curative (C) | 2013-04-18 | 2013-06-03 | AML18 PILOT TRIAL | N | N | 220027551 | PILOT TRIAL |
| 220019330 | 220007174 | 1.85 | 90 | Curative (C) | 2016-02-03 | 2016-02-03 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027553 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019331 | 220013956 | null | 62 | Curative (C) | 2014-05-07 | 2014-08-03 | AML18 PILOT TRIAL | Y | N | 220027583 | PILOT TRIAL |
| 220019332 | 220007182 | 1.81 | 64.8 | Curative (C) | 2013-04-28 | 2013-05-04 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027594 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019333 | 220017598 | 1.61 | 56 | Curative (C) | 2013-12-15 | 2013-12-23 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027595 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019334 | 220007185 | 1.91 | 89.65 | Curative (C) | 2014-05-28 | 2014-06-15 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 220027600 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019335 | 220007191 | 1.82 | 69.3 | Curative (C) | 2016-06-04 | 2016-06-08 | AML 18 TRIAL | 1 | N | 220027617 | AML18 TRIAL |
| 220019336 | 220007197 | 1.71 | 89.3 | Curative (C) | null | 2015-04-19 | AML18 PILOT TRIAL | Y | null | 220027658 | PILOT TRIAL |
| 220019337 | 220007201 | 1.8 | 91.1 | Curative (C) | 2014-09-15 | 2014-11-23 | AML18 PILOT TRIAL | null | N | 220027659 | PILOT TRIAL |
| 220019338 | 220013967 | 1.7 | 78.4 | Curative (C) | 2015-09-26 | 2015-10-02 | AML 18 TRIAL | 01 | N | 220027663 | AML18 TRIAL |
| 220019339 | 220007204 | 1.5 | 65.7 | Curative (C) | 2015-08-06 | 2015-09-24 | AML 18 TRIAL | 1 | N | 220027665 | AML18 TRIAL |
| 220019340 | 220007213 | 1.67 | 87.1 | Curative (C) | 2014-10-08 | 2014-12-16 | AML 18 TRIAL | N | N | 220027691 | AML18 TRIAL |
| 220019341 | 220007217 | 1.49 | 0 | Palliative (P) | 2016-02-11 | 2016-02-11 | Dasatinib | N | N | 220027703 | DASATINIB |
| 220019342 | 220007221 | 1.63 | 0 | Curative (C) | 2017-11-20 | 2017-11-20 | Dasatinib | N | N | 220027709 | DASATINIB |
| 220019343 | 220007222 | 1.78 | 133 | Curative (C) | 2016-04-08 | 2016-04-09 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | null | 220027726 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019344 | 220007230 | 1.6 | null | Disease modification (D) | 2016-11-29 | 2016-12-06 | Rituximab | N | N | 220027754 | RITUXIMAB |
| 220019345 | 220007233 | 1.57 | 89.3 | Curative (C) | 2013-07-10 | 2013-11-08 | AML18 PILOT TRIAL | Y | N | 220027773 | PILOT TRIAL |
| 220019346 | 220007235 | 1.5 | 82.2 | Curative (C) | 2015-05-20 | 2015-05-20 | Dasatinib | 02 | N | 220027774 | DASATINIB |
| 220019347 | 220007240 | 1.63 | null | Palliative (P) | 2010-07-19 | 2013-05-17 | Dasatinib | N | N | 220027806 | DASATINIB |
| 220019348 | 220007247 | 1.63 | 63.1 | Curative (C) | 2012-02-23 | 2013-08-10 | Dasatinib | N | N | 220027816 | DASATINIB |
| 220019349 | 220013987 | 1.62 | 46.3 | Curative (C) | 2014-09-17 | 2014-10-30 | AML18 PILOT TRIAL | 1 | N | 220027821 | PILOT TRIAL |
| 220019350 | 220007250 | 1.67 | null | Disease modification (D) | 2018-05-20 | 2018-05-21 | Dasatinib | 2 | N | 220027826 | DASATINIB |
| 220019351 | 220017616 | 1.77 | null | Adjuvant (A) | 2015-02-09 | 2015-02-09 | Dasatinib | 02 | null | 220027828 | DASATINIB |
| 220019352 | 220007252 | 1.67 | 77.9 | Disease modification (D) | 2014-12-23 | 2014-12-23 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027831 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019353 | 220007254 | 1.62 | 95.2 | Curative (C) | 2015-06-05 | 2016-01-26 | Rituximab | N | N | 220027834 | RITUXIMAB |
| 220019354 | 220019654 | 1.77 | 65.8 | Curative (C) | 2017-11-20 | 2017-12-01 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220027861 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019355 | 220007260 | 1.55 | null | Curative (C) | 2014-12-31 | 2015-01-01 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | 220027874 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019356 | 220007260 | 1.67 | 65.7 | Palliative (P) | 2014-05-03 | 2014-05-03 | Dasatinib | 2 | N | 220027874 | DASATINIB |
| 220019357 | 220013996 | 1.86 | 75 | Curative (C) | 2018-05-30 | 2018-05-31 | Rituximab | Y | N | 220027894 | RITUXIMAB |
| 220019358 | 220007265 | 1.69 | 78 | Curative (C) | 2015-05-18 | 2015-06-02 | Rituximab | N | null | 220027906 | RITUXIMAB |
| 220019359 | 220007269 | 1.79 | 57.8 | Curative (C) | 2017-06-24 | 2017-06-29 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 220027908 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019360 | 220014003 | 1.61 | 98.9 | Curative (C) | 2016-02-24 | 2016-04-07 | AML 18 TRIAL | Y | N | 220027940 | AML18 TRIAL |
| 220019361 | 220017626 | 1.93 | 61.2 | Curative (C) | 2017-09-13 | 2017-12-01 | AML18 PILOT TRIAL | Y | null | 220027944 | PILOT TRIAL |
| 220019362 | 220007280 | 1.63 | 0 | Disease modification (D) | 2017-02-16 | 2017-02-16 | Rituximab | N | null | 220027960 | RITUXIMAB |
| 220019363 | 220007282 | 1.53 | 78.6 | Adjuvant (A) | 2015-03-25 | 2015-05-20 | Dasatinib | N | N | 220027982 | DASATINIB |
| 220019364 | 220007296 | 1.69 | null | Curative (C) | 2015-06-09 | 2015-11-28 | Dasatinib | N | N | 220028090 | DASATINIB |
| 220019365 | 220020848 | 1.58 | 70 | Curative (C) | 2017-01-31 | 2017-01-31 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220028109 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019366 | 220007298 | 0 | 59.5 | Disease modification (D) | 2016-08-05 | 2016-08-07 | Rituximab | 02 | N | 220028118 | RITUXIMAB |
| 220019367 | 220007299 | 1.77 | 77.7 | Disease modification (D) | 2013-04-17 | 2013-08-14 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220028136 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019368 | 220007302 | 1.62 | 71.8 | Palliative (P) | 2013-08-26 | 2013-08-27 | AML 18 TRIAL | N | N | 220028138 | AML18 TRIAL |
| 220019369 | 220007304 | 0 | 79.6 | Curative (C) | 2017-02-12 | 2017-03-17 | Rituximab | N | N | 220028139 | RITUXIMAB |
| 220019370 | 220007305 | 1.8 | null | Curative (C) | 2016-02-08 | 2016-02-09 | Dasatinib | N | N | 220028145 | DASATINIB |
| 220019371 | 220007307 | null | 95.2 | Disease modification (D) | 2014-05-27 | 2014-09-19 | AML18 PILOT TRIAL | N | N | 220028151 | PILOT TRIAL |
| 220019372 | 220020852 | 1.79 | 54 | Curative (C) | 2016-12-21 | 2016-12-21 | Rituximab | N | N | 220028152 | RITUXIMAB |
| 220019373 | 220007311 | 1.7 | 49.9 | null | 2013-07-21 | 2013-09-13 | AML 18 TRIAL | Y | N | 220028170 | AML18 TRIAL |
| 220019374 | 220007313 | 1.9 | 76.75 | Curative (C) | 2015-10-29 | 2016-01-01 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220028174 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019376 | 220017645 | 1.7 | 83 | Curative (C) | 2015-04-01 | 2015-04-01 | AML18 PILOT TRIAL | N | N | 220028201 | PILOT TRIAL |
| 220019377 | 220022207 | 0 | 72 | Curative (C) | 2015-12-02 | 2016-03-08 | AML18 PILOT TRIAL | N | N | 220028203 | PILOT TRIAL |